Price T Rowe Associates Inc Zai Lab LTD Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Price T Rowe Associates Inc holds 153,037 shares of ZLAB stock, worth $4.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,037
Previous 2,268,216 93.25%
Holding current value
$4.99 Million
Previous $82 Million 93.47%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$24.32 - $43.03 $51.4 Million - $91 Million
-2,115,179 Reduced 93.25%
153,037 $5.35 Million
Q1 2025

May 14, 2025
SELL
$24.29 - $38.35 $2.08 Million - $3.29 Million
-85,809 Reduced 3.65%
2,268,216 $82 Million
Q4 2024

Feb 14, 2025
BUY
$24.61 - $33.18 $13.5 Million - $18.2 Million
548,378 Added 30.37%
2,354,025 $61.7 Million
Q3 2024

Nov 14, 2024
BUY
$16.25 - $24.14 $2.4 Million - $3.57 Million
147,732 Added 8.91%
1,805,647 $43.6 Million
Q2 2024

Aug 14, 2024
BUY
$13.72 - $21.55 $97,796 - $153,608
7,128 Added 0.43%
1,657,915 $28.7 Million
Q1 2024

May 15, 2024
SELL
$15.95 - $26.8 $16.8 Million - $28.2 Million
-1,053,668 Reduced 38.96%
1,650,787 $26.4 Million
Q4 2023

Feb 14, 2024
SELL
$22.97 - $30.58 $278,832 - $371,210
-12,139 Reduced 0.45%
2,704,455 $73.9 Million
Q3 2023

Nov 14, 2023
BUY
$22.72 - $31.49 $2.08 Million - $2.88 Million
91,479 Added 3.48%
2,716,594 $66 Million
Q2 2023

Aug 14, 2023
BUY
$25.3 - $39.67 $5.46 Million - $8.56 Million
215,742 Added 8.95%
2,625,115 $72.8 Million
Q1 2023

May 15, 2023
BUY
$30.21 - $48.1 $27.9 Million - $44.4 Million
923,108 Added 62.11%
2,409,373 $80.1 Million
Q4 2022

Feb 14, 2023
SELL
$22.28 - $38.71 $2.71 Million - $4.7 Million
-121,416 Reduced 7.55%
1,486,265 $45.6 Million
Q3 2022

Nov 14, 2022
BUY
$34.2 - $51.69 $4.83 Million - $7.3 Million
141,271 Added 9.63%
1,607,681 $55 Million
Q2 2022

Aug 15, 2022
SELL
$23.14 - $49.68 $1.24 Million - $2.66 Million
-53,607 Reduced 3.53%
1,466,410 $50.9 Million
Q1 2022

May 16, 2022
BUY
$27.77 - $64.4 $4.03 Million - $9.34 Million
145,053 Added 10.55%
1,520,017 $66.9 Million
Q4 2021

Feb 14, 2022
BUY
$54.9 - $105.21 $450,015 - $862,406
8,197 Added 0.6%
1,374,964 $86.4 Million
Q3 2021

Nov 15, 2021
BUY
$105.0 - $178.37 $27.6 Million - $46.9 Million
262,800 Added 23.81%
1,366,767 $144 Million
Q2 2021

Aug 16, 2021
BUY
$125.11 - $180.0 $5.29 Million - $7.62 Million
42,319 Added 3.99%
1,103,967 $195 Million
Q1 2021

May 17, 2021
BUY
$126.27 - $191.71 $19.3 Million - $29.3 Million
152,819 Added 16.81%
1,061,648 $142 Million
Q4 2020

Feb 16, 2021
BUY
$81.94 - $135.34 $74.5 Million - $123 Million
908,829 New
908,829 $123 Million

Others Institutions Holding ZLAB

# of Institutions
170
Shares Held
38.6M
Call Options Held
150K
Put Options Held
201K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.19B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email